Price Controls On Prescription Drugs Could Have Adverse Effect On Life Spans, Study Says

Placing price controls on prescription drugs in the U.S. would result in modest cost savings but would shorten life spans as the pace of drug innovation slowed, according to a study in Health Affairs, Reuters reports. Some policymakers recently suggested that the U.S.

More: continued here

Filed under: Health Insurance / Medical Insurance on December 19th, 2008